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Neutrophil recruitment to inflammation sites purport-
edly depends on sequential waves of chemoattrac-
tants. Current models propose that leukotriene B4
(LTB4), a secondary chemoattractant secreted by
neutrophils in response to primary chemoattractants
such as formyl peptides, is important in initiating
the inflammation process. In this study we demon-
strate that LTB4 plays a central role in neutrophil
activation and migration to formyl peptides. We
show that LTB4 production dramatically amplifies
formyl peptide-mediated neutrophil polarization
and chemotaxis by regulating specific signaling
pathways acting upstream of actin polymerization
and MyoII phosphorylation. Importantly, by analyz-
ing the migration of neutrophils isolated from wild-
type mice and mice lacking the formyl peptide
receptor 1, we demonstrate that LTB4 acts as a signal
to relay information from cell to cell over long
distances. Together, our findings imply that LTB4 is
a signal-relay molecule that exquisitely regulates
neutrophil chemotaxis to formyl peptides, which
are produced at the core of inflammation sites.
INTRODUCTION
Neutrophils are the most abundant leukocytes in the blood
stream and the first cells recruited to an inflammation site, where
primary chemoattractants such as formyl peptides released from
bacteria or necrotic cells and complement fragments are
produced (McDonald et al., 2010). In response to primary
chemoattractants, the surrounding tissue as well as resident
immune cells, such asmacrophages, release secondary chemo-
attractants (Monteiro et al., 2011; Ribeiro et al., 1997). These pro-
inflammatory mediators activate nearby endothelia and enhance
leukocyte extravasation (Soehnlein et al., 2009). After neutrophils
have entered the tissue, gradients of secondary chemoattrac-
tants guide neutrophils toward the vicinity of the inflammation.
Locally, gradients of primary chemoattractants recruit neutro-
phils to the core of the inflammation (Foxman et al., 1997; HeitDevelopmet al., 2002). After they have reached the inflammation site,
neutrophils in turn secrete secondary chemoattractants and
recruit additional leukocytes, which further amplify the inflamma-
tion process (Silva, 2010).
It has been proposed that secondary chemoattractants are
secreted in sequential waves (McDonald and Kubes, 2010),
where leukotriene B4 (LTB4) is the first secondary chemoattrac-
tant released at an inflammation site (Chou et al., 2010;
Kim et al., 2006). LTB4 is a product of arachidonic acid (AA)
metabolism. It is synthesized by the sequential action of 5-lipox-
ygenase (5-LO) and leukotriene A4 hydrolase (LTA4H) (Crooks
and Stockley, 1998; Peters-Golden and Henderson, 2007) and
mediates its effects by binding to the G protein-coupled receptor
BLT-1 (McDonald et al., 1992; Tager and Luster, 2003). LTB4 is
a potent chemoattractant for neutrophils and a key player in
the initiation of inflammation (Canetti et al., 2003; Grespan
et al., 2008; Ramos et al., 2005). Indeed, Chen et al. demon-
strated that the recruitment of neutrophils toward inflammation
sites is dependent on 5-LO expression in neutrophils (Chen
et al., 2006a).
The current model suggests that LTB4, as a secondary chemo-
attractant, is released once neutrophils reach the site of inflam-
mation (McDonald and Kubes, 2010). We hypothesize that
LTB4 is actively secreted by neutrophils as they are migrating
toward formyl peptides, therefore acting as a signal-relay mole-
cule. To test this hypothesis, we assessed the role of LTB4
secretion during primary neutrophil activation and migration in
response to formyl peptides. We find that LTB4 significantly
amplifies neutrophil recruitment to primary chemoattractants
by selectively modulating signaling cascades involved in cell
polarization and by serving as a potent secondary gradient.
Thus, LTB4 acts as a signal-relay molecule for neutrophils
migrating toward formyl peptides.
RESULTS
LTB4 Secretion Does Not Alter fMLP-Induced ERK
and PI3K Activation
We show that in response to the formyl peptide fMLP (N-formyl-
methionine-leucine-phenylalanine), primary human neutrophils
rapidly secrete LTB4 in a concentration-dependent manner
(Figure 1A), as previously established (Dahinden et al., 1988).
Because LTB4 and fMLP both bind to Gai protein-coupledental Cell 22, 1079–1091, May 15, 2012 ª2012 Elsevier Inc. 1079
Figure 1. LTB4 Secretion Does Not Alter fMLP-Induced ERK and PI3K Activation
(A) fMLP-induced LTB4 secretion by neutrophils is dose dependent. Primary human neutrophils were stimulated with fMLP for 1 min, and the amount of LTB4 in
the supernatant was determined by ELISA. Results represent the average ± SEM of four independent experiments.
(B) LTB4 secretion does not amplify Erk1/2 and Akt phosphorylation upon stimulation with subsaturating doses of fMLP. Primary human neutrophils were
stimulated with 1 nM fMLP after pretreatment with either 100 nMMK866, 10 mMLY223982, or DMSO as a control. The western blot for the kinetics of activation is
representative of three independent western blot analyses. Also see Figures S1A and S1B.
(C) fMLP-induced LTB4 secretion has no impact on cell adhesion to fibronectin. Primary human neutrophils were treated with either 100 nM MK866, 10 mM
LY223982, or 40 mM LY294002, a PI3K inhibitor. Cells were plated on fibronectin-coated plates for 10 min and uniformly stimulated with different concentrations
of fMLP. The plates were then shaken, and the number of remaining cells attached to the plates was estimated by crystal violet staining. Results represent the
average ± SEM of four independent experiments.
(D) Neutrophil adhesion pattern is not altered upon treatment with LTB4 pathway inhibitors. Neutrophil adhesion to fibronectin-coated plates upon stimulation
with 1 nM fMLPwas observed by IRM in the presence or absence of drugs as described in (C). The areas of close contact of neutrophils to the substratum appear
dark in the IRM image. Representative images are presented.
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LTB4 Signal Relay during Chemotaxisreceptors (BLT-1 and FPR1, respectively) and activate similar
cellular pathways (Berger et al., 2002; Cotton and Claing,
2009; Kuniyeda et al., 2007), we set out to determine if signal
transduction pathways are amplified by fMLP-induced LTB4
secretion in primary human neutrophils. For this purpose we
used two chemical inhibitors: MK886, an inhibitor of 5-LO activity
and subsequent LTB4 production (Gillard et al., 1989); and
LY223982, a BLT1 receptor antagonist, which blocks LTB4-
mediated responses (Jackson et al., 1992).
We first focused our attention on the impact of LTB4 secretion
on PI3K activation because previous reports suggested that the
PI3K-PTEN axis is specifically involved in neutrophil migration
toward LTB4 (Heit et al., 2002, 2008). We observed no significant
difference in the fMLP-mediated phosphorylation of Akt on T308
(mediated through PI3K) (Alessi et al., 1997) in the presence of
either MK886 or LY223982 compared to untreated cells (Fig-
ure 1B and Figure S1A available online). These results are
consistent with the fact that LTB4 gives rise to a lower level of1080 Developmental Cell 22, 1079–1091, May 15, 2012 ª2012 ElseviAkt phosphorylation compared to fMLP (Figure S1B); any
increase in signal mediated by LTB4 would not be significant
compared to the response elicited by fMLP alone. Similarly, we
found that LTB4 signaling has no effect on the fMLP-mediated
phosphorylation of Akt on S473, which is mediated through
mTORC2 (Sarbassov et al., 2005), or of Erk1/2 (Figures 1B,
S1A, and S1B). Together, these findings establish that LTB4
secretion has no impact on Akt and Erk1/2 activation upon
fMLP stimulation.
Because the PI3K pathway has been linked to cell adhesion
(Ferreira et al., 2006; Pellegatta et al., 2001; Shimizu and Hunt,
1996), we also tested the impact of secreted LTB4 on neutrophil
adhesion in response to fMLP. We found that fMLP stimulation
results in a dose-dependent increase in the number of neutro-
phils adhering to a fibronectin-coated surface (Figure 1C). As
previously reported, we also found that PI3K inhibition by
LY294002 treatment dramatically reduces the capacity of
neutrophil to adhere (Oakes et al., 2009). In contrast, ander Inc.
Figure 2. LTB4 Secretion Enhances fMLP-Induced cAMP Production and MyoII Phosphorylation
(A) LTB4 secretion has no impact on intracellular cAMP accumulation in neutrophils stimulated with a saturation dose of fMLP. Primary human neutrophils were
treated with 100 nM MK886 or 10 mM LY223982 or DMSO as control and stimulated with 1 mM fMLP. Intracellular cAMP levels were determined by ELISA at the
indicated time points. Results represent the average ± SEM of three independent experiments.
(B) LTB4 inhibition reduces cAMP accumulation in neutrophils treated with a subsaturating dose of fMLP. Primary human neutrophils were treated as in (A) and
stimulated with 1 nM fMLP. Results represent the average ± SEM of three independent experiments. *p < 0.05, ANOVA; Dunnett post hoc test. Also see Figures
S2A and S2B.
(C) LTB4 secretion amplifies phosphorylated MyoII levels in response to subsaturating doses of fMLP. Primary human neutrophils were plated on fibronectin-
coated plates for 10 min and stimulated uniformly with 1 nM fMLP in the presence or absence of drugs as described in (A). The western blot for the kinetics of
activation is representative of three independent western blot analyses. Also see Figure S2C.
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LTB4 Signal Relay during Chemotaxisconsistent with our results of PI3K activation, no alteration in the
adhesion capacity of neutrophils was detected in the presence
of either MK886 or LY223982 (Figure 1C). Finally, comparison
of neutrophil-substrate contact area using interference reflection
microscopy (IRM) revealed no significant difference between cell
contact areas in response to 1 nM fMLP in the presence of LTB4
pathway inhibitors (Figure 1D). These data confirm that PI3K
modulates neutrophil adhesion and is not affected by LTB4
secretion following fMLP addition.
Autocrine and Paracrine LTB4 Secretion Enhances
fMLP-Induced Cell Polarization
We recently reported that the fMLP-mediated activation of the
adenylyl cyclase 9 (AC9) and the subsequent accumulation of
intracellular cAMP are important for neutrophil polarization and
back retraction (Liu et al., 2010). We, therefore, set out to deter-
mine whether fMLP-induced LTB4 secretion alters intracellular
cAMP dynamics at subsaturating and saturating doses of
fMLP (FPR1 KD = 1 nM) (Migeotte et al., 2006). We found that
LTB4 pathway inhibitors do not impact the fMLP-mediated
cAMP accumulation when fMLP is presented under saturating
conditions (1 mM) (Figure 2A). In sharp contrast, both MK866
and LY223982 dose-dependently inhibited the ability of fMLP
to induce cAMP production under subsaturation conditions
(1 nM) (Figures 2B, S2A, and S2B). These findings establish
that LTB4 secretion is required to elicit intracellular cAMP
accumulation following stimulation with 1 nM fMLP. BecauseDevelopmintracellular cAMP accumulation regulates uropod dynamics
via a PKA/MyoII axis (Liu et al., 2010), we next measured the
effect of fMLP-induced LTB4 secretion on the extent of myosin
light-chain MyoII phosphorylation in neutrophils stimulated
with 1 nM of fMLP. In accordance with our cAMP measure-
ments, we found that the levels of fMLP-induced MyoII phos-
phorylation are significantly reduced in the presence of LTB4
pathway inhibitors (Figures 2C and S2C). These data suggest
that fMLP-induced LTB4 secretion affects uropod dynamics
during chemotaxis.
We next determined the role of fMLP-induced LTB4 secretion
in fMLP-mediated actin polymerization and cell polarity. In
response to a uniform stimulation of chemoattractant, neutro-
phils first accumulate cortical F-actin evenly around their
periphery in a so-called cringe response; they then polarize
and acquire a network of branched F-actin at their leading
edge (Figure 3A) (Orelio and Kuijpers, 2009). When stimulated
with 1 mM fMLP, the amount of F-actin in neutrophils doubles
within 20 s and remains high up to 5min (Figure 3B). Under these
conditions, 83% of neutrophils accumulate cortical F-actin after
30 s, and 85%of neutrophils are polarized after 2min (Figure 3D).
Pretreating neutrophils with LTB4 pathway inhibitors has no
effect on this outcome (Figures 3B and 3D). These results illus-
trate that the drugs have no toxic effect on the capacity of cells
to polymerize actin and that LTB4 secretion has no impact on
F-actin dynamics and cell polarization following saturating stim-
ulations of fMLP.ental Cell 22, 1079–1091, May 15, 2012 ª2012 Elsevier Inc. 1081
Figure 3. Autocrine and Paracrine LTB4 Secretion Enhances fMLP-Induced Cell Polarization
(A) Different stages of neutrophil polarization can be observed in response to fMLP stimulation. Primary human neutrophils were plated on gelatin-coated plates.
Cells were stimulated, fixed, and F-actin was stained with FITC-phalloidin. Representative images are presented.
(B) LTB4 secretion has no impact on neutrophil response to a saturating dose of fMLP. Primary human neutrophils were treated with 100 nM MK886 or 10 mM
LY223982 or DMSO as control, stimulated with 1 mM fMLP, fixed, and the F-actin network was stained with FITC-phalloidin. The kinetics of the average fluo-
rescence was determined by FACS analysis. Results represent the average ± SEM of three independent experiments.
(C) Neutrophil treatment with LTB4 inhibitors reduces neutrophil polarization in response to subsaturating doses of fMLP. Primary human neutrophils were treated
as in (B), stimulated with 1 nM fMLP, and F-actin levels were determined by FACS, after staining with FITC-phalloidin. Results represent the average ± SEM of
three independent experiments. *p < 0.005, ANOVA; Dunnett post hoc test.
(D) LTB4 amplifies neutrophil polarization after 2 min of fMLP stimulation. Primary human neutrophils were treated as in (B), plated on gelatin-coated plates,
stimulated with fMLP, and fixed at different time points. Cells were stained with F-actin and counted into three categories (unpolarized, accumulated cortical
F-actin, polarized). Results represent the average of four independent experiments.
(E) LTB4 amplifies neutrophil polarization in an autocrine and paracrinemanner. Primary human neutrophils were treated as in (B), plated on gelatin-coated plates
at different cell densities for 10 min. After 2 min stimulation with 1 nM fMLP, cells were fixed, and the number of polarized cells was counted. Results represent
the average ± SEM of three independent experiments. *p < 0.05, ANOVA; Dunnett post hoc test.
See also Figure S3.
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LTB4 Signal Relay during ChemotaxisWhen neutrophils are stimulated with the subsaturating dose
of 1nM fMLP, the F-actin accumulation follows a biphasic profile
with peaks at 20 s and 1 min after stimulation (Figure 3C). The
first peak of F-actin correlates in time with the cortical cringe
response, whereas the second peak matches the polarized
F-actin response (Figure 3D). Under these conditions, after
2 min of stimulation, 67% of cells are polarized, whereas 25%
show high cortical F-actin staining (Figure 3D). Remarkably,
treatment with either MK886 or LY223982 specifically ablates
the second F-actin (Figure 3C). Indeed, after 2min of stimulation,
we found that MK886 and LY223982 treatments decreased the
percentage of polarized cells to only 34% and 26%, respectively
(Figure 3D). Not surprisingly, we also found that the extent of
F-actin accumulation following sub- and saturating IL-8 stimula-
tions, which only lead to low LTB4 secretion (Figure S3A) (Meliton1082 Developmental Cell 22, 1079–1091, May 15, 2012 ª2012 Elseviet al., 2010), is not altered in the presence of LTB4 pathway inhib-
itors (Figures S3B and S3C). These data demonstrate that LTB4
secretion facilitates and stabilizes neutrophil polarization in
response to subsaturating stimulations of fMLP. Under these
conditions we propose that the limited MyoII phosphorylation
measured is a consequence of the absence of cell polarization;
we did not observe neutrophil back-retraction defects.
We next wanted to assess if the effects of LTB4 on fMLP-medi-
ated neutrophil polarization were mediated in an autocrine or
paracrine fashion. To answer this question, we plated neutro-
phils at decreasing densities, which gradually reduces the
effects of any paracrine signals, and measured the extent of
neutrophil polarity 2 min after the addition of 1 nM fMLP. We
observed a significant decrease in the percentage of polarized
cells as we decreased cell density (Figure 3E), suggesting thater Inc.
Figure 4. AA Accumulates at the Front of Polarized Neutrophils
(A) Bright-field and CARS images of deuterated punctates localized in polarized primary human neutrophils migrating to 1 mM fMLP in under-agarose assay.
Representative images of polarized cells untreated (upper panel) or treated with MK886 (lower panel) are presented. The false-colored chemical images for
nucleus (blue), cytoplasm (gray), and deuterated punctates (red) were constructed from Raman intensities at 2,952 cm1 and 2,850 cm1 for nucleus, and
intensities at 2,900 cm1 for cytoplasm, and 2,250 cm1 for deuterated punctates, respectively. The asterisks represent the direction of migration. The scale bar
represents 5 mm.
(B) Location parameters of deuterated punctates in neutrophils are plotted for two differently treated neutrophils. The location parameter is defined as (number
of punctates at the front)/(total number of punctates). Neighboring image pixels (greater than four pixels) are counted as one regardless of the overall size.
# p = 0.009, Wilcoxon test.
(C) Comparison of the CARS spectra of deuterated punctates found in polarized neutrophils under the indicated conditions.
See also Figure S4.
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LTB4 Signal Relay during Chemotaxisa paracrine signal regulates neutrophil polarization in response
to fMLP. Because this effect is markedly inhibited in the pres-
ence of MK886 or LY223982, we propose that LTB4 acts as
the main paracrine factor in this response. With 1 nM fMLP stim-
ulations, the paracrine effect is lost when neutrophil density
is lower than 105 cells/cm2 because no further decrease in
the percentage of polarized cells is observed at 105 and 0.5 3
105 cells/cm2. However, at these cell densities, treatment with
either LTB4 pathway inhibitor still significantly reduces the
proportion of polarized cells (Figure 3E), suggesting that LTB4
also acts in an autocrine fashion. Taken together, these data
demonstrate that, at subsaturating fMLP concentrations,
secreted LTB4 functions as a paracrine and autocrine signal to
enhance and stabilize neutrophil polarization.
AA Accumulates at the Front of Polarized Neutrophils
We next set out to determine if LTB4 secretion is directionally
biased in polarized neutrophils. However, intracellular LTB4
has never been detected in neutrophils stimulated with eitherDevelopmfMLP or ionomycin (a major 5-LO activator) (Mita et al., 1988;
Williams et al., 1985), suggesting that LTB4 does not accumulate
to significant levels in neutrophils. To circumvent this issue, we
assessed the subcellular localization of the LTB4 precursor,
AA, in polarized neutrophils using coherent anti-Stokes Raman
scattering (CARS) microscopy.
Cells pretreated with deuterated AA were allowed to polarize
and migrate directionally to fMLP using the under-agarose
assay, fixed and analyzed by CARS to determine the subcellular
distribution of deuterated species. We detected characteristic
spectra for cytoplasm, nucleus, and deuterated punctates
(Figure S4A). The peak at z2,250 cm1 is characteristic of
carbon-deuterium (C-D) bound, whereas the broad peaks
at z2,900 cm1 are a signature of carbon-hydrogen (C-H)
bounds. Remarkably, we found that deuterated punctates
accumulate toward the leading edge of neutrophils during
chemotaxis (Figures 4A and 4B). In sharp contrast the inhibition
of LTB4 synthesis with MK866 rendered the distribution of AA
deuterated punctates random (Figures 4A and 4B). Importantly,ental Cell 22, 1079–1091, May 15, 2012 ª2012 Elsevier Inc. 1083
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LTB4 Signal Relay during Chemotaxisthese findings were not a consequence of the weak cellular
polarization measured in the presence of LTB4 pathway inhibi-
tors because similar findings were obtained when deuterated
punctates were monitored following a uniform stimulation with
a saturating dose of fMLP (1 mM), which gives rise to normal
polarization.
We next compared the averaged spectrum of the deuterated
punctates of untreated and MK886-treated cells and found no
difference between the two conditions (Figure 4C; see also Fig-
ure S4B for a zoomed-in view of the spectra of the C-D bound),
even though simulations suggest that the CARS spectra of
deuterated AA and deuterated LTB4 should be different (Fig-
ure S4C). Similarly, no deuterated LTB4 signal could be identified
in neutrophils stimulated for longer periods (data not shown) or
stimulated with the potent activator of 5-LO, ionomycin (Figures
4C and S4B) (Ford-Hutchinson et al., 1980). It, therefore,
appears that, as previously suggested (Mita et al., 1988;Williams
et al., 1985), LTB4 does not accumulate in migrating neutrophils.
We see two possible interpretations of our data: (i) AA is
enriched at the front of polarized neutrophils because most of
the AA at the back of cells has been converted into LTB4, which
is then secreted at the cell rear; or (ii) AA is relocalized at the front
of neutrophils in response to 5-LO activation. Interestingly, we
measured the asymmetrical distribution of deuterated punctates
in neutrophils as early as 1 min after a uniform stimulation with
1 nM fMLP (data not shown), before the peak of LTB4 secretion
(Figure S4D). This finding suggests that AA is actively redistrib-
uted to the front of neutrophils and that LTB4 is not primarily
generated and secreted at the back of cells.
LTB4 Autocrine/Paracrine Secretion Amplifies
Neutrophil Chemotaxis to fMLP
Because cellular polarization is a prerequisite for migration, we
studied the role of LTB4 paracrine/autocrine secretion in neutro-
phil chemotaxis. We found that treating neutrophils with either
MK886 or LY223982 significantly reduces transwell migration
to fMLP (Figure 5A). Not surprisingly, neutrophil migration to
IL-8 (which induces a very low LTB4 secretion; Figure S3A) is
not altered in the presence of LTB4 pathway inhibitors (Fig-
ure S3D). This finding also confirms that the LTB4 inhibitors
used are specific and do not directly impact neutrophil migration.
This finding was further investigated using the under-agarose
assays, where the behavior of populations of cells can be visual-
ized directly (Heit and Kubes, 2003) (Figure 5B). We found that
treatment with LTB4 pathway inhibitors drastically reduces
neutrophil chemotaxis to fMLP compared to untreated cells.
The inhibition is statistically significant and more dramatic
when cells migrated toward lower concentrations of fMLP
(Figures 5B and 5C). The reduction in neutrophil chemotaxis in
this assay could arise because cells cannot penetrate under
the agarose in the absence of LTB4 signaling or because
fMLP-induced LTB4 secretion amplifies chemotaxis. To get at
this, we measured the extent of directed migration as a function
of time; we found that in response to either 500 nM or 1 mM fMLP,
LTB4 pathway inhibitors give rise to a gradual inhibition of
migration (Figures 5D and 5E), which is indicative of a chemo-
tactic defect. Indeed, if cells were unable to migrate under the
agarose, we would expect the migration profiles to show a
time delay but otherwise be similar.1084 Developmental Cell 22, 1079–1091, May 15, 2012 ª2012 ElseviIt has been shown that fMLP gradients in under-agarose
assays are neither linear nor stable over time (Ude´n et al.,
1986). We took advantage of this to study how a neutrophil
population migrates into different gradients by assessing the
migration speed of cells as a function of the chemoattractant
gradient (Figure S5). We found that when neutrophils migrate in
either shallow (lower than 25 pM/mm) or steep (greater than
60 pM/mm) gradients, the inhibition of LTB4 has no significant
impact on group migration (Figure 5F). Interestingly, when
neutrophils migrate in intermediate gradients (between 25 and
60 pM/mm), the population migrates more efficiently, i.e., the
front of migration progresses faster toward the well containing
fMLP, in the presence of LTB4 paracrine/autocrine secretion
(Figure 5F). These data are consistent with the fact that
fMLP-induced LTB4 secretion impacts cell polarization at subsa-
turating (more physiological) concentrations of primary chemo-
attractants. More importantly, the data highlight the fact that
LTB4 paracrine/autocrine secretion is effective under conditions
where LTB4 is produced in sufficient amounts (i.e., in response to
>20 pM/mm) and not overwhelmed by the high concentration of
primary chemoattractant (>60 pM/mm).
LTB4 Paracrine Secretion Acts as a Signal Relay
between Neutrophils
We showed that fMLP-induced LTB4 secretion favors neutrophil
polarization and chemotaxis in shallow primary chemoattractant
gradients. Several models could explain these observations.
First, LTB4 could increase the capacity of neutrophils to sense
fMLP, e.g., by enhancing expression of the fMLP receptor.
Second, LTB4 could act as a chemokinetic agent and simply
increase neutrophil migratory capacity. Finally, LTB4 secretion
could form a secondary gradient that facilitates a directional
recruitment of neighboring neutrophils. In order to test these
possibilities, we took advantage of the availability of mice that
lack the formyl receptor 1 (FPR1), which mediates neutrophil
chemotaxis to fMLP (Gao et al., 1999), and tested the ability of
neutrophils isolated from these mice to migrate to exogenous
fMLP when mixed with neutrophils isolated from wild-type (WT)
mice.
We first demonstrated that the importance of LTB4 secretion in
neutrophil migration to formyl peptides is not restricted to human
primary neutrophils. Using the under-agarose assay, we found
that MK886 treatment reduces mouse bone marrow neutrophil
migration to the synthetic WKYMVm peptide (a strong agonist
for the mouse neutrophil FPR; He et al., 2000) (Figure 6A). Simi-
larly to human neutrophils (Figure 5C), the inhibition is more
important for cells migrating to low concentrations of the peptide
(Figure 6A). Moreover, we demonstrate that this is not a conse-
quence of drug-induced toxicity in neutrophils: neutrophils iso-
lated from the bone marrow of mice lacking either BLT1 (blt1/)
(Tager et al., 2000) or 5-LO (alox5/) (Chen et al., 1994) exhibit
impaired migration to 100 nM WKYMVm similarly to what we
measure in neutrophils isolated from WT animals treated with
MK886 (Figure 6B). Not surprisingly, we also confirmed that
neutrophils isolated from fpr1/ mice do not respond to
100 nM MKYMVm (Figure 6B). Importantly, these cells are able
to migrate efficiently to LTB4 (data not shown).
We then mixed cell populations (1:1 ratio) and measured
their ability to migrate directionally to MKYMVm using theer Inc.
Figure 5. Neutrophil Migration to fMLP Is Amplified by fMLP-Induced LTB4 Paracrine/Autocrine Secretion
(A) LTB4 secretion amplifies neutrophil migration to fMLP. The number of primary human neutrophils migrating to 1 mM fMLP in a 4 mm transwell was determined
after 2 hr. Results represent the relative percentage of migrating cells after treatment (average ± SEM) of three independent experiments. *p < 0.05, Friedman test;
Dunn’s post hoc test.
(B) LTB4 secretion amplifies neutrophil chemotaxis to fMLP. Representative images of primary human neutrophils migrating to 1 mM fMLP in the under-agarose
assay are shown.
(C) LTB4 secretion amplifies neutrophil chemotaxis to fMLP. The distance migrated by primary human neutrophils treated with LTB4 pathway inhibitors is
compared to the onemigrated by untreated cells. Results represent the relative distancemigrated (average ± SEM, n = 3) in under-agarose assay in 2 hr. *p < 0.05,
Friedman test; Dunn’s post hoc test.
(D and E) Kinetics of neutrophil migration in under-agarose assays. The distance migrated by primary human neutrophils to either 1 mM fMLP (D) or 500 nM fMLP
(E) was determined at different times points. Results represent the average ± SEM of three independent experiments.
(F) Impactof LTB4secretiononneutrophilmigration todifferent fMLPgradients. Foreachsegmentof 20minofmigration, theaveragespeedwasdetermined,and the
local gradient of the front ofmigrationwasdeterminedusing theoretical charts (see FigureS5). The resultingdifferent data points (speedversus gradient) areplotted.
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LTB4 Signal Relay during Chemotaxisunder-agarose assay. To distinguish between the different pop-
ulations, mutant neutrophils were fluorescently labeled. We first
confirmed that the fluorescent label does not alter neutrophil
migration (Figure 6C). Interestingly, we found that, in the pres-
ence of neutrophils derived fromWT animals, fpr1/ neutrophils
gain the capacity to migrate directionally to a well containing
MKYMVm. Most importantly, the recruitment of fpr1/ neutro-
phils is abolished when WT neutrophils are treated with MK886
and do not produce LTB4. Similarly, fpr1
/ neutrophils are not
recruited when mixed with neutrophils isolated from the bone
marrow of alox5/ mice (Figure 6C).
Together, these findings establish that LTB4 acts as a signal-
relay molecule for neutrophils where WT neutrophils releaseDevelopmLTB4 in an autocrine/paracrine fashion, which provides spatial
information to neighboring fpr1/ neutrophils. This LTB4 relay
allows the fpr1/ neutrophils to migrate directionally to a che-
moattractant they cannot sense.
DISCUSSION
LTB4 is widely recognized as an essential mediator in inflamma-
tion. Inhibiting leukotriene production reduces leukocyte recruit-
ment and inflammation in a variety of models, such as arthritis,
pancreatitis, or asthma (Peters-Golden and Henderson, 2007).
Here, we establish that LTB4 is not only a secondary
chemoattractant for neutrophils secreted early in theental Cell 22, 1079–1091, May 15, 2012 ª2012 Elsevier Inc. 1085
Figure 6. LTB4 Is a Signal-Relay Molecule for Neutrophils
(A) MK886 treatment regulates murine neutrophil migration to MKYMVm. Neutrophils isolated from the bone marrow of WT mouse were allowed to migrate to
MKYMVm in the under-agarose assay. The number of neutrophils migrating to fMLPwas determined after 5 hr of migration. Results represent the average ± SEM
number of migrating mouse neutrophils in three independent experiments. *p < 0.05, Mann-Whitney U test.
(B) LTB4 secretion amplifies murine neutrophil migration to MKYMVm. Neutrophils isolated from the bone marrow of mice were allowed to migrate to 100 nM
MKYMVm in the under-agarose assay. The number of neutrophils migrating was determined after 5 hr of migration. Results represent the average ± SEM number
of migrating mouse neutrophils in three independent experiments. *p < 0.05, Friedman test; Dunn’s post hoc test.
(C) Neutrophils that do not senseMKYMVmcan still migrate toMKYMVmwhenmixedwithWT neutrophils secreting LTB4. Neutrophils isolated from fpr1
/mice
were fluorescently labeled and mixed with WT neutrophils (pretreated or not with 100 nM MK886) or neutrophils isolated from alox5/ mice. The number of
fluorescent and nonfluorescent cells that migrate to 100 nM MKYMVm was determined after 5 hr migration. Results represent the average ± SEM number of
migrating mouse neutrophils in three independent experiments. *p < 0.05, Friedman test; Dunn’s post hoc test.
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LTB4 Signal Relay during Chemotaxisinflammation process, but it is also an important signal-relay
molecule that increases the recruitment range and promotes
the directional migration of neutrophils to formyl peptides, which
are released at the core sites of inflammation (McDonald et al.,
2010).
We demonstrate that LTB4 relay amplifies cAMP production,
MyoII phosphorylation, F-actin polymerization, and cell polariza-
tion when cells are stimulated with subsaturating doses of
fMLP. This is reminiscent to what has been described in the
social amoebae Dictyostelium discoideum, where efficient
effector activation requires the autocrine/paracrine production
of chemoattractants when cells are stimulated with subsaturat-
ing concentrations of chemoattractant (Das et al., 2011). By
contrast, and similar to the Dictyosteliummodel, LTB4 secretion
has no impact on effector activation when neutrophils are stimu-
lated with saturating concentrations of fMLP. These findings also
support previous findings (Rochon and Frojmovic, 1993; Tom-
have et al., 1994), where at saturating concentrations of fMLP,
FPR1 activation induces BLT1 desensitization. Furthermore, we
found that LTB4 pathway inhibition specifically impactsmigration
speed at intermediary fMLP gradients. In this case we envision
that under very shallow fMLP gradients, LTB4 production is too
low to impact fMLP-induced response, whereas under very
steep gradients, LTB4 has no impact on migration because of
cross-desensitization.Wepropose that this intermediarywindow
of fMLP concentrations, where LTB4 relay is a key amplifier, may
represent physiologically relevant conditions for in vitro studies.1086 Developmental Cell 22, 1079–1091, May 15, 2012 ª2012 ElseviBoth BLT1 and FPR1 are coupled to Gai-bg G proteins, and
neutrophil migration toward either LTB4 or formyl peptides is
pertussis toxin sensitive (Brito et al., 1997). Therefore, one
would expect that LTB4 relay amplifies the same signaling path-
ways as formyl peptides. However, we show that LTB4 relay
specifically amplifies signaling pathways leading to F-actin
production and MyoII phosphorylation without affecting Akt
and Erk1/2 activation. Differences in signaling pathway activa-
tion upon formyl peptides and LTB4 stimulation have been
previously reported: fMLP-induced chemotaxis has been shown
to require P38-MAPK activation, whereas migration to LTB4 is
P38 independent (Heit et al., 2002). Similarly, BLT1 activation
does not induce H2O2 production, whereas FPR1 activation
induces a high pertussis toxin-sensitive H2O2 production, and
b2-integrin upregulation has been reported to be three times
higher upon fMLP stimulation compared to LTB4 stimulation
(Berger et al., 2002). Several models can be proposed to explain
how the activation of a given Ga subunit can result in different
functional responses. First, although the functional relevance
of bg subtypes has yet to be fully appreciated, the Gai subunits
could associate with different bg subunits when coupled to
different receptors—this has been demonstrated for the musca-
rinic M4 and somatostatin receptors binding to Gao (Kleuss
et al., 1992, 1993). Second, FPR1 and BLT1 have been reported
to partition in different lipid domains at the plasma membrane
(Sitrin et al., 2006). In this context we envision that effector
molecules and activated receptors could access different lipider Inc.
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LTB4 Signal Relay during Chemotaxisdomains resulting in the spatial segregation of signal transduc-
tion pathways.
fMLP-induced LTB4 secretion amplifies neutrophil polarization
in an autocrine manner. In fact at low cell density, when LTB4
cannot act as a paracrine factor, fMLP-induced LTB4 still
enhances neutrophil polarization, albeit to a lesser extent. LTB4
is not the only autocrine factor associated with effective cell
polarization. It has been shown that autocrine ATP secretion
enhances lamellipodia formation and stabilization in macro-
phage and neutrophil chemotaxis to C5a and fMLP, respectively
(Chen et al., 2006b; Kronlage et al., 2010). Interestingly, the ATP
autocrine activity has been associated with its directed release
at the leading edge. We provide evidence that LTB4 could simi-
larly be secreted at the front of neutrophils. We propose that in
both cases the asymmetric secretion enhances lamellipod
formation and stabilizes cell polarization by creating a local
gradient at the leading edge.
In contrast to ATP, however, we also found that LTB4 acts in
a paracrine fashion to enhance recruitment of neutrophils to
primary chemoattractants. Previous studies have also sug-
gested that LTB4 secretion could act as a paracrine effector for
efficient neutrophil activation and degranulation in response to
LTB4 or ATP, respectively (Kannan, 2002; Serio et al., 1997).
We predict that both in vivo and in vitro, the secondary gradient
generated by the secretion of LTB4 can efficiently recruit a popu-
lation of neutrophils that may not normally be recruited to sites of
inflammation. This is of consequence because human primary
neutrophil populations are heterogeneous. For example three
distinct neutrophil subsets, which respond differently to infec-
tious agents, have been identified during Staphylococcus aureus
infection in mice (Tsuda et al., 2004). In this context, neutrophils
that can efficiently migrate to formyl peptides would readily
secrete LTB4, thereby recruiting populations of neutrophils that
are low responders for formyl peptides but are good LTB4
responders. Similarly, in Dictyostelium, signal relay has been
shown to specifically amplify the range of recruitment of neigh-
boring cells to an external chemoattractant allowing cells to
maintain directionality over very long distances (McCann et al.,
2010).
It remains unclear how the secondary LTB4 gradient is formed.
Due to its small size (molecular weight = 336 Da), LTB4 would
likely diffuse quickly rendering the gradient short lived. We could
first argue that LTB4 is a lipid-derived hydrophobic molecule,
which could significantly reduce its diffusion properties. Second,
neutrophils could create a more stable gradient by secreting
LTB4 in exosomes. In Dictyostelium, signal relay has been
proposed to be mediated by the secretion of chemoattractant-
containing exosomes (Kriebel et al., 2008), and FLAP-containing
exosomes have been detected in neutrophils (Jethwaney
et al., 2007). In addition a recent report has demonstrated that
macrophages and dendritic cells are capable of secreting
LTB4-producing exosomes (Esser et al., 2010), which can induce
granulocyte migration. Hence, we speculate that neutrophils
may secrete such exosomes. In this model, neutrophils that
migrate to sites of inflammation would recruit additional neutro-
phils with LTB4-releasing vesicles. This model is consistent with
our current study and others where intracellular LTB4 has not
been detected (Mita et al., 1988; Williams et al., 1985). This
suggests that either LTB4 is secreted quickly out of the cells orDevelopmthat the cytosolic production of LTB4 is weak. In this latter
scenario, LTB4 production could be contained within extracel-
lular vesicles.
Based on our findings, we propose the following model for
LTB4-mediated signal relay (see Figure 7). In response to a given
external formyl peptide gradient, some neutrophils respond,
polarize, and release LTB4 or LTB4-producing vesicles at their
leading edge. The local LTB4 gradient strengthens and stabilizes
cell polarization of the first responders. Because LTB4 produc-
tion is fMLP concentration dependent, neutrophils that are closer
to the fMLP source will secrete higher amounts of LTB4. As
a consequence, a secondary LTB4 gradient is formed parallel
to the fMLP gradient. Neutrophils that were not initially respon-
sive to fMLP can now sense the secondary gradient of LTB4
andmigrate up this gradient toward the fMLP source, thus ampli-
fying the inflammatory response.
In summary we provide a mechanism where directional cell-
to-cell communication regulates neutrophil migration and
recruitment to the core of inflammation sites. We envision this
mechanism to be important in vivo where the relay of LTB4
signals would enhance neutrophil recruitment to the inflamma-
tion core at the initiation of the process, when low concentrations
of primary chemoattractants are released. In addition we predict
that LTB4 relay is poised to maintain the inflammation. In fact it
has been shown that in the absence of LTB4 signaling, experi-
mentally induced arthritis subsides faster (Chen et al., 2006a;
Chou et al., 2010). We propose that in these models, directed
neutrophil recruitment to the core of inflammation is enhanced
by LTB4 signal relay.
EXPERIMENTAL PROCEDURES
Additional information is found in the Supplemental Experimental Procedures.
Materials
Percoll, Histopaque 1077, formyl peptides (fMLP for human neutrophils, and
the synthetic WKYMVm peptide for mouse neutrophils), IL-8, ionomycin, and
LY294002 were obtained from Sigma-Aldrich (St. Louis). LTB4, deuterated
AA, the FLAP inhibitor MK886, and the LTB4 receptor antagonist LY223982
were purchased from Cayman Chemical (Ann Arbor, MI, USA). Anti-p-Akt
(clone C31E5E and D9E for residues T308 and S473, respectively), anti-phos-
phorylated myosin light chain 2 (Ser19), and anti-p-Erk1/2 (clone D13.14.4E)
rabbit antibodies were all from Cell Signaling Technology (Beverly, MA,
USA). Transwell chambers were purchased from Corning Life Sciences
(Lowell, MA, USA). WT, alox5/, and blt1/ mice were from the Jackson
Laboratory (Bar Harbor, ME, USA). Fpr1/ mice were a generous gift from
Philip Murphy (National Institute of Allergy and Infectious Diseases, National
Institutes of Health [NIH]).
Isolation of Human Peripheral Blood Neutrophils
Heparinized whole blood was obtained by venipuncture from healthy donors.
Neutrophils were isolated by dextran sedimentation (3% dextran/0.9% NaCl)
coupled to differential centrifugation over Histopaque 1077 (Mahadeo et al.,
2007). Residual erythrocytes were removed using hypotonic lysis with 0.2%
and 1.6% saline solutions. Blood samples were obtained from anonymous
blood donors enrolled in the NIH Blood Bank research program.
Isolation of Mouse Bone Marrow Neutrophils
Mice were sacrificed, and the femurs and tibias were removed from both legs.
HBSS (without calcium and magnesium) with 0.1% BSA was forced through
the bones, and the solution was filtered trough a cell strainer. Cells were centri-
fuged at 400 3 g for 5 min, and neutrophils were isolated using a three-layer
Percoll gradient of 78%, 69%, and 52%, as previously described (Boxioental Cell 22, 1079–1091, May 15, 2012 ª2012 Elsevier Inc. 1087
Figure 7. Model for LTB4 as a Signal-Relay Molecule for Neutrophils Migrating to fMLP
In response to an external fMLP gradient, some neutrophils respond, polarize, and release LTB4. The local LTB4 gradient strengthens and stabilizes cell
polarization of these first responders. Because LTB4 production is fMLP concentration dependent, a secondary LTB4 gradient is formed parallel to the fMLP
gradient. Neutrophils that were not initially responsive to fMLP sense the secondary gradient of LTB4 and migrate up this gradient toward the fMLP source, thus
amplifying the inflammatory response.
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LTB4 Signal Relay during Chemotaxiset al., 2004). After isolation, neutrophils were resuspended in HBSS with or
without 1 mM cytotracker green (Molecular Probes; Invitrogen, Eugene, OR,
USA), incubated for 1 hr at 37C, washed, resuspended in RPMI with 10%
serum, and incubated for 1 hr at 37C. Animal procedures were done under
protocols approved by the National Cancer Institute, in accordance with Asso-
ciation for Assessment and Accreditation of Laboratory Animal Care guidelines
and policies established by the NIH.
LTB4 Measurement
LTB4 was measured using an ELISA kit (R&D Systems, Minneapolis). Human
primary neutrophils were resuspended at 1 3 106 cells/ml in PBS and incu-
bated for 30 min on ice. GM-CSF (10 ng/ml; R&D Systems) was added, and
neutrophils were further incubated for 1 hr at 37C. Cells were spun down at
400 3 g for 5 min and resuspended (cell density = 15 3 106 cells/ml) with
RPMI and incubated at 37C until stimulated. After the stimulation, cold PBS
was quickly added, neutrophils were centrifuged, and supernatants were
collected and frozen. Assays were performed according to manufacturer’s
instructions.
Under-Agarose Assay
Chemotaxis of the neutrophil population was studied using the under-agarose
assay as previously described (Comer and Parent, 2006). Cell culture dishes
were coated with 1% BSA in PBS for 1 hr at 37C. For assays with human
peripheral blood neutrophils, 0.5% agarose in 50% PBS-50% mHBSS was
poured and allowed to solidify for 40min. For assays with mouse bone marrow
neutrophils, 1.2% agarose in 50%PBS-40%RPMI-10% FBSwas used. Three
1-mm-diameter wells were carved at 2 mm distance from each other. A
chemoattractant was placed in the middle well 15 min before plating neutro-
phils. A total of 5 3 105 neutrophils in 5 ml mHBSS was plated in the outer
wells and incubated at 37C. Human peripheral blood neutrophils were
allowed to chemotax for 2 hr unless otherwise mentioned, and mouse bone1088 Developmental Cell 22, 1079–1091, May 15, 2012 ª2012 Elsevimarrow neutrophils were allowed to chemotax for 5 hr. The wells with
human peripheral blood neutrophils were visualized using a Leica DM IL
stereoscope. Assays using human peripheral blood neutrophils were quanti-
fied using ImageJ by measuring the distance the cells had migrated direction-
ally toward the chemoattractant. For the mouse bone marrow neutrophils,
fluorescent cells were counted using a Zeiss Axiovert S100 epifluorescent
microscope.
CARS Microscopy
Neutrophils were incubated with deuterated AA as reported previously (van
Manen et al., 2005). Labeled cells were allowed to migrate in under-agarose
assay for 2 hr, or stimulated uniformly for 1 or 2 min with 10 nM fMLP. The
experimental setup of the broadband CARS microscopy has been described
previously (Lee et al., 2011; Parekh et al., 2010). Briefly, the output (70 fs,
centered at 830 nm, 80 MHz) of a Ti:S laser oscillator (MaiTai-DeepSee,
Spectra-Physics) was split into two parts. One part was introduced into
a photonic crystal fiber (Crystal Fibre; FemtoWHITE) to generate a continuum
pulse. The other part was spectrally narrowed by a 4-f dispersion-less filter to
10 cm1 full-width half-maximum (FWHM) with the center wavelength at
830 nm. The two beams were introduced collinearly and with parallel polariza-
tion into a 603 1.35 NA oil-immersion objective lens (Olympus) and focused on
the sample. The CARS signal generated from the sample was collected in the
forward direction and passed through a set of an 830 nm notch filter and an
810 nm short-pass filter and was analyzed using a charge-coupled device
(CCD; DU920-BR-DD; Andor) attached to amonochromator (SP-2300; Acton).
The spatial resolutionwas laterally 500 nm, and the sample was scanned either
by 120 or 250 nm pixel spacing. The average laser power at the sample was
kept below 15 mW for each pulse to avoid photodamage. The CCD exposure
time is typically 30 ms per pixel. The acquired CARS spectrum was processed
bymodified Kramers-Kronig phase retrieval and followed by baseline detrend-
ing (Liu et al., 2009).er Inc.
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Analyses were performed with GraphPad Prism software Version 5.0b. One-
way ANOVA and Dunnet post hoc test (with untreated cells as the control
group) were performed on normalized data with ‘‘treatment’’ as the indepen-
dent variable and ‘‘cAMP level,’’ ‘‘F-actin accumulation,’’ or ‘‘number of cells
migrating in a transwell assay’’ as the dependent variable (p < 0.05was consid-
ered statistically significant). Friedman and Dunn’s post hoc test (with
untreated cells as the control group) was performed with ‘‘treatment’’ as the
independent variable and ‘‘normalized MyoII phosphorylation levels’’ or
‘‘distance migrated in under-agarose assay’’ as the dependent variable
(p < 0.05 was considered statistically significant). For the asymmetrical distri-
bution we compared the distribution to a theoretical 0.5 mean value in a
Wilcoxon test.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
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